Early Solid Tumor Diagnosis Through Next-Generation Sequencing of Cell-Free DNA
- 31 October 2018
- journal article
- editorial
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 12 (11) , 1197-1201
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinomaPLOS ONE, 2017
- Tumor volume determines the feasibility of cell‐free DNA sequencing for mutation detection in non‐small cell lung cancerCancer Science, 2016
- Consensus on precision medicine for metastatic cancers: a report from the MAP conferenceAnnals of Oncology, 2016
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seqScience, 2016
- Crossroad between linear and nonlinear transcription concepts in the discovery of next-generation sequencing systems-based anticancer therapiesDrug Discovery Today, 2016
- Chromosomal Instability in Cell-Free DNA Is a Serum Biomarker for Prostate CancerClinical Chemistry, 2015
- Discovery and saturation analysis of cancer genes across 21 tumour typesNature, 2014
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- Architecture of the human regulatory network derived from ENCODE dataNature, 2012
- Identification of Functional Elements and Regulatory Circuits by Drosophila modENCODEScience, 2010